Moleculin Biotech Inc (MBRX)
2.90
+0.07
(+2.47%)
USD |
NASDAQ |
Nov 22, 15:59
Moleculin Biotech Market Cap: 8.706M for Nov. 22, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 21, 2024 | 8.495M |
| November 20, 2024 | 8.015M |
| November 19, 2024 | 7.85M |
| November 18, 2024 | 7.565M |
| November 15, 2024 | 8.135M |
| November 14, 2024 | 9.276M |
| November 13, 2024 | 7.535M |
| November 12, 2024 | 7.925M |
| November 11, 2024 | 7.535M |
| November 08, 2024 | 7.655M |
| November 07, 2024 | 7.024M |
| November 06, 2024 | 6.904M |
| November 05, 2024 | 7.325M |
| November 04, 2024 | 7.355M |
| November 01, 2024 | 7.355M |
| October 31, 2024 | 7.805M |
| October 30, 2024 | 7.625M |
| October 29, 2024 | 7.865M |
| October 28, 2024 | 7.865M |
| October 25, 2024 | 7.730M |
| October 24, 2024 | 7.625M |
| October 23, 2024 | 7.655M |
| October 22, 2024 | 7.655M |
| October 21, 2024 | 8.015M |
| October 18, 2024 | 7.760M |
| Date | Value |
|---|---|
| October 17, 2024 | 7.084M |
| October 16, 2024 | 7.265M |
| October 15, 2024 | 6.994M |
| October 14, 2024 | 7.114M |
| October 11, 2024 | 7.325M |
| October 10, 2024 | 7.295M |
| October 09, 2024 | 7.655M |
| October 08, 2024 | 7.505M |
| October 07, 2024 | 7.535M |
| October 04, 2024 | 7.084M |
| October 03, 2024 | 7.385M |
| October 02, 2024 | 7.565M |
| October 01, 2024 | 8.375M |
| September 30, 2024 | 8.525M |
| September 27, 2024 | 7.822M |
| September 26, 2024 | 6.941M |
| September 25, 2024 | 6.855M |
| September 24, 2024 | 7.652M |
| September 23, 2024 | 7.709M |
| September 20, 2024 | 6.742M |
| September 19, 2024 | 6.998M |
| September 18, 2024 | 7.026M |
| September 17, 2024 | 6.656M |
| September 16, 2024 | 6.855M |
| September 13, 2024 | 6.912M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
5.622M
Minimum
Aug 08 2024
156.31M
Maximum
Feb 10 2021
44.05M
Average
40.36M
Median
Nov 29 2022
Market Cap Benchmarks
| Agilent Technologies Inc | 38.46B |
| Seelos Therapeutics Inc | 0.1308M |
| Cara Therapeutics Inc | 16.93M |
| Citius Pharmaceuticals Inc | 24.31M |
| NovaBay Pharmaceuticals Inc | 3.349M |
Market Cap Related Metrics
| Price to Book Value | 1.164 |
| Price | 2.90 |
| Earnings Yield | -406.0% |